×

Equipment and Services Health Care Equipment and Supplies

  • NORTH CHICAGO, Ill.— Abbott Laboratories' first-quarter profit jumped nearly 33 percent, helped by its acquisition of medical device maker St. Jude Medical earlier this year. Its $25 billion deal to buy St. Jude Medical was completed in January. Revenue rose about 30 percent to $6.34 billion in the period, which topped the $6.11 billion that analysts surveyed by...

  • April 18- U.S. drug distributor Cardinal Health Inc agreed to buy medical device maker Medtronic Plc's medical supplies units for $6.1 billion and said it expected full-year adjusted earnings at the lower end of its forecast. Cardinal Health, which had forecast adjusted profit in the range of $5.35- $5.50 per share, blamed generic price deflation for the...

  • April 18- U.S. drug distributor Cardinal Health Inc said on Tuesday it would buy medical device maker Medtronic Plc's medical supplies businesses for $6.1 billion in cash. Cardinal Health is acquiring the patient care, deep vein thrombosis and nutritional insufficiency units from Medtronic. Cardinal Health said it would finance the acquisition with cash...

  • Stocks are closing broadly higher on Wall Street, giving the market its biggest gain in six weeks. Wells Fargo jumped 2.7 percent. Medical device maker Alere soared 16 percent after it agreed to new terms for a sale to Abbott Laboratories.

  • The FDA, which said the company failed to disclose at least one death associated with one of the devices, said an inspection of the company's facility in Sylmar, California, raised questions about the safety of several implantable defibrillators and its Merlinzhome monitor, which allows doctors to care remotely for patients with cardiac devices.

  • April 12- Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show. The product was launched in Europe, Canada and Australia in 2016.. Its backers include the venture capital firms New Enterprise...

  • April 9- Shares of Glaukos Corp could fall 30 percent in the next year, as years of success by the medical device maker has attracted competition from larger companies that threaten its market share, according to the April 10 edition of Barron's. Glaukos shares have risen 150 percent to around $50 since June 2015, trading at 300 times expected earnings and 10 times...

  • Protesters demonstrate against President Donald Trump and his plans to end Obamacare outside the White House in Washington, March 23, 2017.

    "Huge shocks from the political system are always a distraction," athenahealth's Jonathan Bush told CNBC.

  • March 30- Boston Scientific Corp on Thursday agreed to buy Swiss medical device maker Symetis SA for $435 million, looking to bolster its presence in Europe after recalling a range of heart valves in the region. The company's Acurate systems will broaden Boston Scientific's TAVR range to include additional designs and delivery methods that cover more...

  • March 30- Boston Scientific Corp said on Thursday it would buy Swiss medical device maker Symetis SA for $435 million, a deal that will help the U.S. company expand in the European market. Boston Scientific in February recalled its Lotus valve devices from Europe and other regions following reports of a faulty locking mechanism. The acquisition would allow...

  • March 30- Boston Scientific Corp said on Thursday it would buy privately held Symetis SA for $435 million to expand its minimally invasive heart devices business. Swiss medical device maker Symetis said it has halted its IPO launch, its second attempt to go public. The company was expecting to raise up to 61.5 million euros and list on the Euronext Paris by March...

  • March 30- Boston Scientific Corp said on Thursday it would buy privately-held Swiss medical device maker Symetis SA for $435 million to expand its business of making minimally invasive heart devices.

  • Woman dentist

    Jim Cramer sees a hidden bull market in the fast-growing dental industry.

  • Can this non-Trump play keep climbing?

    Jim Cramer sees a hidden bull market in the fast-growing dental industry.

  • Cramer finds a refreshingly non-Trump play in this stealthy sector

    Jim Cramer sees a hidden bull market in the fast-growing dental industry.

  • The Food and Drug Administration said it approved Bavencio, known chemically as avelumab, to treat metastatic Merkel cell carcinoma in patients 12 years and older. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in a statement. About 1,600 people in the United States are diagnosed with MCC every year, according to the National Cancer...

  • NEW YORK, March 16- U.S. stocks slipped on Thursday pressured by healthcare shares as traders cashed in gains from one of the best performing sectors so far this year. Proposals in President Donald Trump's budget signaled higher regulatory costs for the sector and a cut in federal funding for medical research. Biogen weighed down the S&P 500, falling 4.7 percent...

  • TRUMP BUDGET PROPOSES TO MORE THAN DOUBLE FEES FOR COMPANIES SEEKING FDA REVIEW OF DRUGS AND MEDICAL DEVICES.

  • NEW YORK, March 13- Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that U.S. "They are putting up good numbers from a growth perspective and they seem like they're in a little cocoon from the political drug pricing debate," said Walter Todd, chief investment officer of...

  • WASHINGTON, March 10- The White House is expected as early as Friday to nominate Dr. Scott Gottlieb, a physician and conservative health policy expert, to lead the U.S. Food and Drug Administration, sources familiar with the matter said. If confirmed by the Senate, Gottlieb would be in charge of implementing President Donald Trump's plan to dramatically cut...